Paclitaxel alleviated sepsis-induced acute lung injury by activating MUC1 and suppressing TLR-4/NF-κB pathway

PURPOSE: It has been reported that approximately 40% of ALI (acute lung injury) incidence resulted from sepsis. Paclitaxel, as a classic anti-cancer drug, plays an important role in the regulation of inflammation. However, we do not know whether it has a protective effect against CLP (cecal ligation...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:Drug Des Devel Ther
Autori principali: Wang, Yu-Ming, Ji, Ran, Chen, Wei-Wei, Huang, Shun-Wei, Zheng, Yan-Jun, Yang, Zhi-Tao, Qu, Hong-Ping, Chen, Hao, Mao, En-Qiang, Chen, Ying, Chen, Er-Zhen
Natura: Artigo
Lingua:Inglês
Pubblicazione: Dove 2019
Soggetti:
Original Research
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC6766586/
https://ncbi.nlm.nih.gov/pubmed/31576113
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/DDDT.S222296
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi